2023-04-01 2024-03-31 false Capium Accounts Production 1.1 11266254 2023-04-01 2024-03-31 11266254 bus:AbridgedAccounts 2023-04-01 2024-03-31 11266254 bus:FRS102 2023-04-01 2024-03-31 11266254 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 11266254 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 11266254 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 11266254 2023-04-01 2024-03-31 11266254 2024-03-31 11266254 bus:RegisteredOffice 2023-04-01 2024-03-31 11266254 core:WithinOneYear 2024-03-31 11266254 core:AfterOneYear 2024-03-31 11266254 1 2023-04-01 2024-03-31 11266254 bus:Director1 2023-04-01 2024-03-31 11266254 bus:Director1 2024-03-31 11266254 bus:Director1 2022-04-01 2023-03-31 11266254 bus:Director2 2023-04-01 2024-03-31 11266254 bus:Director2 2024-03-31 11266254 bus:Director2 2022-04-01 2023-03-31 11266254 2022-04-01 11266254 bus:LeadAgentIfApplicable 2023-04-01 2024-03-31 11266254 2022-04-01 2023-03-31 11266254 2023-03-31 11266254 core:WithinOneYear 2023-03-31 11266254 core:AfterOneYear 2023-03-31 11266254 bus:EntityAccountantsOrAuditors 2022-04-01 2023-03-31 11266254 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 11266254 bus:OrdinaryShareClass1 2024-03-31 11266254 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 11266254 bus:OrdinaryShareClass1 2023-03-31 11266254 core:PlantMachinery 2023-04-01 2024-03-31 11266254 core:PlantMachinery 2024-03-31 11266254 core:PlantMachinery 2023-03-31 11266254 core:FurnitureFittings 2023-04-01 2024-03-31 11266254 core:FurnitureFittings 2024-03-31 11266254 core:FurnitureFittings 2023-03-31 11266254 core:ComputerEquipment 2023-04-01 2024-03-31 11266254 core:ComputerEquipment 2024-03-31 11266254 core:ComputerEquipment 2023-03-31 11266254 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 11266254 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-03-31 11266254 core:OtherResidualIntangibleAssets 2023-04-01 2024-03-31 11266254 core:OtherResidualIntangibleAssets 2024-03-31 11266254 core:OtherResidualIntangibleAssets 2023-03-31 11266254 core:NetGoodwill 2023-04-01 2024-03-31 11266254 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 11266254 core:CostValuation core:Non-currentFinancialInstruments 2023-03-31 11266254 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-03-31 11266254 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 11266254 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 11266254 core:Non-currentFinancialInstruments 2024-03-31 11266254 core:Non-currentFinancialInstruments 2023-03-31 11266254 core:ShareCapital 2024-03-31 11266254 core:ShareCapital 2023-03-31 11266254 core:RetainedEarningsAccumulatedLosses 2024-03-31 11266254 core:RetainedEarningsAccumulatedLosses 2023-03-31 11266254 dpl:Item1 2023-04-01 11266254 dpl:Item1 2024-03-31 11266254 dpl:Item1 2022-04-01 11266254 dpl:Item1 2023-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11266254


 

 

 

THE READING PHARMACY LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 April 2023

End date: 31 March 2024
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Intangible fixed assets 3 205,833    253,333 
Tangible fixed assets 4 73,971    64,204 
279,804    317,537 
Current assets      
Stocks 41,510    17,000 
Debtors 406,505    139,461 
Cash at bank and in hand 700    69,128 
448,715    225,589 
Creditors: amount falling due within one year (649,197)   (229,254)
Net current assets (200,482)   (3,665)
 
Total assets less current liabilities 79,322    313,872 
Creditors: amount falling due after more than one year   (279,698)
Provisions for liabilities (263)   (539)
Net assets 79,059    33,635 
 

Capital and reserves
     
Called up share capital 5 100    100 
Profit and loss account 78,959    33,535 
Shareholders' funds 79,059    33,635 
 


For the year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 17 January 2025 and were signed on its behalf by:


-------------------------------
Soumick Sikdar
Director
1
General Information
THE READING PHARMACY LIMITED is a private company, limited by shares, registered in , registration number 11266254, registration address UNIT 3 - 4 CAMPBELL COURT, BRAMLEY TADLEY, London, RG26 5EG.

The presentation currency is £ sterling.
1.

Accounting policies

Going concern basis
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Intangible assets
Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
Goodwill
Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of years.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery 20 Reducing Balance
Improvements to property 10 Straight Line
Stocks
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees

Average number of employees during the year was 7 (2023 : 12).
3.

Intangible fixed assets

Cost Other   Total
  £   £
At 01 April 2023 475,000    475,000 
Additions  
Disposals  
At 31 March 2024 475,000    475,000 
Amortisation
At 01 April 2023 221,667    221,667 
Charge for year 47,500    47,500 
On disposals  
At 31 March 2024 269,167    269,167 
Net book values
At 31 March 2024 205,833    205,833 
At 31 March 2023 253,333    253,333 


4.

Tangible fixed assets

Cost or valuation Plant and Machinery   Fixtures and Fittings   Computer Equipment   Improvements to property   Total
  £   £   £   £   £
At 01 April 2023 20,000      44,603    20,900    85,503 
Additions   20,000        20,000 
Disposals     (3,954)     (3,954)
At 31 March 2024 20,000    20,000    40,649    20,900    101,549 
Depreciation
At 01 April 2023 17,333      1,876    2,090    21,299 
Charge for year 2,000      2,189    2,090    6,279 
On disposals        
At 31 March 2024 19,333      4,065    4,180    27,578 
Net book values
Closing balance as at 31 March 2024 667    20,000    36,584    16,720    73,971 
Opening balance as at 01 April 2023 15,394      30,000    18,810    64,204 


5.

Share Capital

Allotted, called up and fully paid
2024
£
  2023
£
100 Ordinary shares of £1.00 each 100    100 
100    100 

2